Advertisement

LINC01140 Alleviates the Oxidized Low-Density Lipoprotein-Induced Inflammatory Response in Macrophages via Suppressing miR-23b

  • Liping He
  • Xingsheng ZhaoEmail author
  • Leping He
Original Article

Abstract

Our previous study has demonstrated that miR-23b enhances oxidized low-density lipoprotein (oxLDL)-induced inflammatory response of macrophages through the A20/NF-κB signaling pathway, thus contributing to atherosclerosis. This study aims to further investigate the upstream regulators of miR-23b in mediating oxLDL-induced inflammatory response. Human monocyte cell line THP1 was induced to differentiate into macrophages followed by the oxLDL stimulation of inflammatory response. The expression of miR-23b, LINC01140, and p53 mRNA was detected by quantitative PCR. The combination of miR-23b and LINC01140 was confirmed by luciferase reporter assay and RNA immunoprecipitation. The binding of p53 and LINC01140 promoter was determined by luciferase reporter assay. The level of inflammatory cytokines, including MCP-1, TNF-α, and IL-1β, was assessed by enzyme-linked immunosorbent assay. LINC01140 was downregulated, while p53 and miR-23b were upregulated in oxLDL-induced inflammatory response of macrophages. Overexpression of LINC01140 reduced NF-κB activity by reducing miR-23b and increasing A20. The transcription of LINC01140 was inhibited by binding of p53 and the LINC01140 promoter region. Knockdown of p53 significantly reduced NF-κB activity and level of inflammatory cytokines by promoting LINC01140 expression. Our findings demonstrated that LINC01140 acts as an anti-inflammatory factor through negatively regulating miR-23/A20 axis. In addition, p53 is identified as a transcriptional repressor of LINC01140.

KEY WORDS

long non-coding RNA p53 macrophage NF-κb activity A20 

Notes

Acknowledgments

The study was supported by Scientific and Technological Project of Inner Mongolia Autonomous Region (No. 201602098).

References

  1. 1.
    Leipsic, J., M. Anastasius, and P. Blanke. 2019. Plaque, Pressure, and Risk: The Story Unfolds∗. Journal of the American College of Cardiology 73 (19): 2425–2426.CrossRefGoogle Scholar
  2. 2.
    Pei, C., Y. Zhang, P. Wang, B.J. Zhang, L. Fang, B. Liu, and S. Meng. 2019. Berberine alleviates oxidized low-density lipoprotein-induced macrophage activation by downregulating galectin-3 via the NF-κB and AMPK signaling pathways. Phytotherapy Research 33 (2): 294–308.CrossRefGoogle Scholar
  3. 3.
    Chen, H.-H., K. Keyhanian, X. Zhou, R.O. Vilmundarson, N.A.M. Almontashiri, S.A. Cruz, N.R. Pandey, N. Lerma Yap, T. Ho, C.A. Stewart, H. Huang, A. Hari, M. Geoffrion, R. McPherson, K.J. Rayner, and A.F.R. Stewart. 2015. IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis. Circulation Research 117 (8): 671–683.CrossRefGoogle Scholar
  4. 4.
    Sica, A., and A. Mantovani. 2012. Macrophage plasticity and polarization: in vivo veritas. The Journal of Clinical Investigation 122 (3): 787–795.CrossRefGoogle Scholar
  5. 5.
    Li, K., D. Ching, F.S. Luk, and R.L. Raffai. 2015. Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis. Circulation Research 117 (1): e1–e11.CrossRefGoogle Scholar
  6. 6.
    He, L.-P., X.-S. Zhao, and L.-P. He. 2018. Abnormally expressed miR-23b in Chinese Mongolian at high cardiovascular risk may contribute to monocyte/macrophage inflammatory reaction in atherosclerosis. Bioscience Reports 38 (6): BSR20180673.CrossRefGoogle Scholar
  7. 7.
    Mowel, W.K., J.J. Kotzin, S. McCright, V.D. Neal, and J. Henao-Mejia. 2018. Control of Immune Cell Homeostasis and Function by lncRNAs. Trends in Immunology 39 (1): 55–69.CrossRefGoogle Scholar
  8. 8.
    Sallam, T., J. Sandhu, and P. Tontonoz. 2018. Long Noncoding RNA Discovery in Cardiovascular Disease: Decoding Form to Function. Circulation Research 122 (1): 155–166.CrossRefGoogle Scholar
  9. 9.
    Sun, J.-f., et al. 2018. Roles of Circular RNAs And Their Interactions With MicroRNAs in Human Disorders. Clinical Surgery Research Communications 2 (2): 1–8.CrossRefGoogle Scholar
  10. 10.
    Hadjicharalambous, M.R., B.T. Roux, E. Csomor, C.A. Feghali-Bostwick, L.A. Murray, D.L. Clarke, and M.A. Lindsay. 2019. Long intergenic non-coding RNAs regulate human lung fibroblast function: Implications for idiopathic pulmonary fibrosis. Scientific Reports 9 (1): 6020–6020.CrossRefGoogle Scholar
  11. 11.
    Groh, L., S.T. Keating, L.A.B. Joosten, M.G. Netea, and N.P. Riksen. 2018. Monocyte and macrophage immunometabolism in atherosclerosis. Seminars in Immunopathology 40 (2): 203–214.CrossRefGoogle Scholar
  12. 12.
    Lei, W., et al. 2019. Blockade of NEAT1 represses inflammation response and lipid uptake via modulating miR-342-3p in human macrophages THP-1 cells. Journal of Cellular Physiology 234: 5319–5326.CrossRefGoogle Scholar
  13. 13.
    Yan, L., Z. Liu, H. Yin, Z. Guo, and Q. Luo. 2019. Silencing of MEG3 inhibited ox-LDL-induced inflammation and apoptosis in macrophages via modulation of the MEG3/miR-204/CDKN2A regulatory axis. Cell Biology International 43 (4): 409–420.CrossRefGoogle Scholar
  14. 14.
    J, L., H. GQ, and K. ZP. 2019. Silence of long intergenic noncoding RNA HOTAIR ameliorates oxidative stress and inflammation response in ox-LDL-treated human macrophages by upregulating miR-330-5p. Journal of Cellular Physiology 234 (4): 5134–5142.CrossRefGoogle Scholar
  15. 15.
    Song, P., et al. 2017. A three-lncRNA expression signature associated with the prognosis of gastric cancer patients. Cancer Medicine 6 (6): 1154–1164.CrossRefGoogle Scholar
  16. 16.
    Beermann, J., M.T. Piccoli, J. Viereck, and T. Thum. 2016. Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. Physiological Reviews 96 (4): 1297–1325.CrossRefGoogle Scholar
  17. 17.
    Ceolotto, G., A. Giannella, M. Albiero, M. Kuppusamy, C. Radu, P. Simioni, K. Garlaschelli, A. Baragetti, A.L. Catapano, E. Iori, G.P. Fadini, A. Avogaro, and S. Vigili de Kreutzenberg. 2017. miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways. Cardiovascular Research 113 (13): 1627–1638.CrossRefGoogle Scholar
  18. 18.
    Song, J., et al. 2019. MicroRNA-181a regulates the activation of the NLRP3 inflammatory pathway by targeting MEK1 in THP-1 macrophages stimulated by ox-LDL. Journal of Cellular Biochemistry 0 (0).Google Scholar
  19. 19.
    Mak, A.S. 2014. p53 in cell invasion, podosomes, and invadopodia. Cell Adhesion & Migration 8 (3): 205–214.CrossRefGoogle Scholar
  20. 20.
    Cao, R.Y., et al. 2017. Effects of p53-knockout in vascular smooth muscle cells on atherosclerosis in mice. PLoS One 12 (3): e0175061.CrossRefGoogle Scholar
  21. 21.
    Mazière, C., A. Meignotte, F. Dantin, M.A. Conte, and J.C. Mazière. 2000. Oxidized LDL Induces an Oxidative Stress and Activates the Tumor Suppressor p53 in MRC5 Human Fibroblasts. Biochemical and Biophysical Research Communications 276 (2): 718–723.CrossRefGoogle Scholar
  22. 22.
    Kinscherf, R., R. Claus, M. Wagner, C. Gehrke, H. Kamencic, D. Hou, O. Nauen, W. Schmiedt, G. Kovacs, J. Pill, J. Metz, and H.P. Deigner. 1998. Apoptosis caused by oxidized LDL is manganese superoxide dismutase and p53 dependent. The FASEB Journal 12 (6): 461–467.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of CardiologyPeople’s Hospital of Inner Mongolia Autonomous regionHohhot cityChina
  2. 2.The Center of Computer InformationPeople’s Hospital of Inner Mongolia Autonomous regionHohhotChina

Personalised recommendations